| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.87T | 1.76T | 1.76T | 1.80T | 1.79T |
| Gross Profit | 84.86B | 67.05B | 92.16B | 110.93B | 137.00B |
| EBITDA | 96.50B | 63.25B | 84.49B | 101.71B | 112.77B |
| Net Income | 13.66B | 37.94B | 37.63B | 45.90B | 55.96B |
Balance Sheet | |||||
| Total Assets | 1.28T | 1.27T | 1.18T | 1.11T | 1.09T |
| Cash, Cash Equivalents and Short-Term Investments | 238.81B | 208.65B | 195.06B | 185.37B | 182.64B |
| Total Debt | 195.91B | 173.79B | 92.53B | 48.27B | 45.89B |
| Total Liabilities | 698.11B | 667.07B | 589.80B | 491.15B | 488.62B |
| Stockholders Equity | 571.03B | 589.26B | 585.75B | 610.38B | 590.54B |
Cash Flow | |||||
| Free Cash Flow | 34.62B | -7.26B | 32.38B | 54.52B | 11.24B |
| Operating Cash Flow | 72.22B | 47.73B | 64.33B | 89.95B | 52.02B |
| Investing Cash Flow | -7.26B | -43.87B | -22.43B | -49.42B | -58.94B |
| Financing Cash Flow | -37.09B | 8.94B | -30.78B | -38.62B | -54.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥119.74B | 35.08 | ― | 3.57% | 3.21% | 7.83% | |
72 Outperform | ¥206.44B | 3.64 | 4.72% | 1.66% | 5.05% | 45.00% | |
70 Outperform | ¥24.21B | 10.21 | ― | 2.82% | 2.99% | -9.86% | |
69 Neutral | ¥6.02B | 9.76 | ― | 1.62% | 9.07% | 17.15% | |
64 Neutral | ¥356.49B | 11.50 | 5.53% | 4.35% | 15.68% | 66.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | ¥599.64B | 40.51 | 7.44% | 2.10% | 5.84% | -61.24% |